Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
6995077
Reference Type
Journal Article
Title
Microparticles on the Basis of Segmented Polyurethanes for the Treatment of Tuberculosis
Author(s)
Batyrbekov, EO; Iskakov, R; Kim, M; Zhubanov, B; ,
Year
2009
Publisher
CRC PRESS-TAYLOR & FRANCIS GROUP
Location
BOCA RATON
Page Numbers
96-99
Web of Science Id
WOS:000273330500028
Abstract
The objective of the research is to develop a new drug delivery system based on polyurethane (PU) microparticles for the treatment of tuberculosis by pulmonary administration to the lungs. The synthesis and characterization of polyurethane microcapsules are studied making use three molecular weight polyethylene glycol (PEG) and tolylene-2,4-diisocyanate (TDI). Antitubercular drugs such as isoniazid was incorporated into the polyurethane microcapsules. The effects of nature and concentration of drug and diols were studied by electronic microscope and size distribution by dynamic light scattering analysis. It was shown that the size of microcapsules at maximum distribution band increases also with the PEG length. The size of polymeric microcapsules and size distribution are important factors for their application for pulmonary administration of drug by respiratory way. The size of microparticles is limited to 1-10 mu m. Particles of such size are mainly to be placed in the periphery of the lung and must be phagocytized by alveolar macrophages, the primary site of tuberculosis infection.
Editor(s)
Laudon, M; Romanowicz, B;
ISBN
978-1-4398-1783-4
Conference Name
Nanotech 2009 Conference
Conference Location
Houston, TX
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity